Loading...
XTSX
AVCR
Market cap4mUSD
Jul 09, Last price  
0.07CAD
1D
8.33%
1Q
-7.14%
Jan 2017
-70.45%
IPO
-83.75%
Name

Avricore Health Inc

Chart & Performance

D1W1MN
XTSX:AVCR chart
P/E
P/S
12.34
EPS
Div Yield, %
Shrs. gr., 5y
10.88%
Rev. gr., 5y
74.44%
Revenues
533k
-88.85%
256,243249,042282,2611,459,686305,59283,36183,36183,3615,713156,4671,013,690537,714226,44533,00033,030122,8081,768,3743,485,1474,785,711533,448
Net income
-2m
L+177.62%
-562,090-1,937,735-1,183,009-3,992,659-1,875,565-306,565283,432-733,946-2,200,648-2,819,719-2,613,904-3,486,324-5,391,654-2,112,848-1,332,918-1,746,570-826,597-701,215-668,977-1,857,231
CFO
-789k
L
-371,023-876,722-930,623-3,612,059-673,340-58,663-154,607-539,519-1,484,577-1,927,590-2,064,090-1,767,296-1,725,047-686,407-1,223,396-1,234,154-437,832660,4031,004,615-789,288

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Avricore Health Inc. is a Canadian company specializing in health data and immediate diagnostic technologies. Its core offering is HealthTab, a proprietary platform providing precise, lab-quality point-of-care testing specifically designed for pharmacy environments. The company boasts significant strategic alliances, notably with Shoppers Drug Marts and Abbott. Founded in 1996, the Vancouver, Canada-based enterprise previously operated as Vanc Pharmaceuticals Inc. before officially adopting the name Avricore Health Inc. in October 2018.
IPO date
Jul 31, 2001
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT